33364-92-0 (4-羟基异喹啉,4-Hydroxyisoquinoline)

快速询单

结构式：

4-羟基异喹啉MOL文件

CAS号：

33364-92-0

中文名称：

4-羟基异喹啉

英文名称：

4-Hydroxyisoquinoline

分子式：

C₉H₇NO

分子量：

145.157982110977

4-羟基异喹啉(33364-92-0)名称与标识符

名称

中文别名：

4-羟基异喹啉;

英文别名：

4-Hydroxyisoquinoline;4-HYDROXY-ISOQUINOLINE;3336-49-0;DB-082508;A26437;MFCD00234514;DTXSID20186976;AKOS006280509;PS-5256;4-ISOQUINOLINOL;NSC-153682;J-521570;CS-W019920;4-hydroxyisoquinoline, AldrichCPR;BRN 0114428;EN300-120932;AC-907/25004895;5-21-03-00321 (Beilstein Handbook Reference);4-oxidoisoquinolinium;SY041595;A821745;NSC 153682;J-019163;4-Isoquinolol;DB-028919;AMY4404;BCP23455;AB05248;FSA7EJB9BG;UNII-FSA7EJB9BG;Z1198152661;SB12152;isoquinolin-4-ol;33364-92-0;NSC153682;SCHEMBL276819;4-Hydroxyisoquinoline ISO 9001：2015 REACH;

标识符

InChIKey：

DXTUTXYCHFWRQC-UHFFFAOYSA-N

Inchi：

1S/C9H7NO/c11-9-6-10-5-7-3-1-2-4-8(7)9/h1-6,11H

SMILES：

OC1=CN=CC2C=CC=CC=21

4-羟基异喹啉(33364-92-0)物化性质

实验特性

LogP : 1.94040
PSA : 33.12
沸点 : 425.4°Cat760mmHg
熔点 : 223-225 °C
闪点 : 211.1°C
密度 : 1.26

计算特性

精确分子量 : 145.05281
氢键供体数量 : 1
氢键受体数量 : 2
可旋转化学键数量 : 0
同位素质量 : 145.053
重原子数量 : 11
复杂度 : 138
同位素原子数量 : 0
确定原子立构中心数量 : 0
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
疏水参数计算参考值（XlogP） : 1.7
拓扑分子极性表面积 : 33.1A^2

4-羟基异喹啉(33364-92-0)推荐厂家更多厂家(2)

公司名称	手机号/电话	联系人	QQ	微信	询单
深圳市瑞吉特生物科技有限公司	15813841136 0755-89459231	钦先生	1029374309		询单
上海依赫生物科技有限公司	17721395025 021-68882955	张经理	2423903095		询单

4-羟基异喹啉(33364-92-0)相关文献

1. Naphthalene-dioxygenase catalysed cis-dihydroxylation of bicyclic azaarenes
Claude Chopard,Gildas Bertho,Thierry Prangé RSC Adv. 2012 2 605
2. Geometry-dependent divergence in the gold-catalyzed redox cascade cyclization of o-alkynylaryl ketoximes and nitrones leading to isoindoles
Hyun-Suk Yeom,Youngun Lee,Ji-Eun Lee,Seunghoon Shin Org. Biomol. Chem. 2009 7 4744
3. 1,3-Dipolar character of six-membered aromatic rings. Part XVI. Reactions of benzyne with 3-hydroxypyridine, 1-methyl-3-oxidopyridinium, and related compounds
Nicholas Dennis,Alan R. Katritzky,Stuart K. Parton J. Chem. Soc. Perkin Trans. 1 1976 2285
4. 652. Hydrogen transfer. Part XVI. Dihydrides of nitrogenous heterocycles as hydrogen donors
E. A. Braude,J. Hannah,Reginald Linstead J. Chem. Soc. 1960 3249
5. 1002. The tautomerism of N-heteroaromatic hydroxy-compounds. Part II. Ultraviolet spectra
S. F. Mason J. Chem. Soc. 1957 5010
6. Small-molecule inhibitors of HIF-PHD2: a valid strategy to renal anemia treatment in clinical therapy
Yue Wu,Nan Wang,Yonghua Lei,Tianhan Hu,Qidong You,Xiaojin Zhang Med. Chem. Commun. 2016 7 1271
7. Synthesis of 3-arylisoquinolines by thermolysis of 3-aryl-1,2-dihydroisoquinolin-4(3H)-one salts
David A. Livingstone,Roger D. Waigh J. Chem. Soc. Chem. Commun. 1978 1026
8. Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion
Kar Kheng Yeoh,Mun Chiang Chan,Armin Thalhammer,Marina Demetriades,Rasheduzzaman Chowdhury,Ya-Min Tian,Ineke Stolze,Luke A. McNeill,Myung Kyu Lee,Esther C. Y. Woon,Mukram M. Mackeen,Akane Kawamura,Peter J. Ratcliffe,Jasmin Mecinovi?,Christopher J. Schofield Org. Biomol. Chem. 2013 11 732
9. Inhibition of 2-oxoglutarate dependent oxygenases
Nathan R. Rose,Michael A. McDonough,Oliver N. F. King,Akane Kawamura,Christopher J. Schofield Chem. Soc. Rev. 2011 40 4364
10. 131. The tautomerism of N-heteroaromatic hydroxy-compounds. Part III. Ionisation constants
S. F. Mason J. Chem. Soc. 1958 674